Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
CPHI China Pharma Q3 2011 earnings miss estimates by 346 85 revenue drop pulls shares 12 lower Are funds investing in Prenetics PRE stock Breakout Watch 20260420 DOLE Dole tops Q4 2025 EPS expectations shares rise modestly on 82 percent year over year revenue growth TJX Companies TJX EAF GrafTech International shares surge 5 despite widerthanexpected Q1 loss CEO upbeat on operational turnaround Why Virginia VABK deserves more attention from serious investors 023 20260508 TOON Kartoon Studios posts wide Q3 2018 EPS miss yet stock notches 203 percent gain today MMSI Merit shares sink 905 percent despite Q1 2026 EPS landing 107 percent above consensus analyst estimates Is Athene ATHS stock underperforming FirstService FSV Rallies 082 as Bulls Target 13731 20260518 Ero Copper ERO Delivers Q1 2026 Beat EPS 069 vs 061 Expected Electric Vehicle Sales in Minnesota Lose Momentum as Gas Prices Stir Market Questions Why Bluerock RE BPRE Just Surged 062 Key Levels Ahead 20260514 Tech Gains Fail to Lift Markets as Broad Indexes Slip Cisco Systems Emerges as Key Player in AI Infrastructure Space in 2026 Dollar Edges Lower as Iran Deal Optimism Grows Yen Flirts with Intervention Threshold EU to Ban Brazilian Meat Imports from September as Mercosur Trade Deal Faces Backlash UAA Q1 2026 Earnings EPS Misses Estimates Stock Rises on Potential Optimism Beam Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Expense Discipline XPER Q1 2026 Earnings Earnings Surge on Strong EPS Beat Moodys MCO Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher Amid Cautious Outlook CDE Q1 2026 Earnings EPS Misses Estimates but Stock Rises 23 MSC Industrial Direct MSM Edges Lower Amid Industrial Sector Headwinds HASI Holds Steady Near 4061 as Support and Resistance Levels Come into Focus Church Dwight CHD Holds Steady with Modest Gains as Defensive Appeal Endures MoonLake Immunotherapeutics MLTX Holds Near Support as Biotech Sector Sends Mixed Signals